GENNIEFY
Market News
Latest financial news and analysis from global markets
TSLA
What the Musk–Altman legal battle means for OpenAI, SpaceX IPOs
OpenAI's (OPAI.PVT) Sam Altman was not found liable for Tesla (TSLA) CEO Elon Musk's claims, due to clear-cut statute-of-limitations issues. Yahoo Finance's Julie Hyman and Jake Conley discuss the impacts on OpenAI's and SpaceX's (SPAX.PVT) upcoming initial public offerings (IPOs).
GOOGL
Blackstone and Google form AI infrastructure joint venture focused on TPU cloud expansion
Blackstone Inc (NYSE:BX) and Alphabet's Google have announced a joint venture aimed at developing a new US-based company that will provide dedicated cloud infrastructure centered on Google’s Tensor Processing Units (TPUs). The planned company will offer data center capacity, operations,...
ROKU
This Bullish Roku Trade Seeks A Quick 30% Profit
Roku stock is in a recent uptrend. This options trade could generate potential 30% return in a few weeks.
NVDA
Guggenheim Just Slapped a Buy Rating on StubHub. $12.50 Price Target Bets on the Live Events Boom
Analysts at Guggenheim see a compelling opportunity in live events ticketing. The firm initiated coverage on StubHub Holdings (NYSE:STUB) with a Buy rating and a $12.50 price target, framing the call as a bet on the ongoing experience economy. For prudent investors, the upgrade puts a fresh institutional stamp on a recently public name whose ... Guggenheim Just Slapped a Buy Rating on StubHub. $12.50 Price Target Bets on the Live Events Boom
NVDA
Why Red Cat Stock Dropped Today
Red Cat makes weapons for war -- and soon, perhaps tools for cleaning up after peace is declared.
INTC
Why Red Cat Stock Dropped Today
Red Cat makes weapons for war -- and soon, perhaps tools for cleaning up after peace is declared.
NVDA
UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point
One of Wall Street’s major firms just put its stamp of approval on a specialty pharma name that has been quietly rallying. UBS upgraded Jazz Pharmaceuticals (NASDAQ:JAZZ) to Buy with a $307 price target, signaling the firm sees a constructive setup the market hasn’t yet priced. For long-term investors, the call lands at a moment ... UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point
KO
Coca-Cola vs. PepsiCo: Scale vs. Stability in Revenue
Quarterly results reveal PepsiCo's revenue swings sharply with the seasons, while Coca-Cola maintains a notably more consistent revenue stream.
PEP
Coca-Cola vs. PepsiCo: Scale vs. Stability in Revenue
Quarterly results reveal PepsiCo's revenue swings sharply with the seasons, while Coca-Cola maintains a notably more consistent revenue stream.
AMZN
SEC proposes exemption for tokenizing stocks. What could go wrong?
Scott Melker discusses the US Securities and Exchange Commission's (SEC) proposed innovation exemption for tokenizing securities without the issuer's permission, using Apple (AAPL) stock as an example. “The Daily Wolf with Scott Melker” airs on Yahoo Finance every day at 12:00 p.m. Tune in for your daily dose of all things crypto. Make sure to also check out Yahoo Finance's new crypto hub to find the latest crypto-related news.
AAPL
SEC proposes exemption for tokenizing stocks. What could go wrong?
Scott Melker discusses the US Securities and Exchange Commission's (SEC) proposed innovation exemption for tokenizing securities without the issuer's permission, using Apple (AAPL) stock as an example. “The Daily Wolf with Scott Melker” airs on Yahoo Finance every day at 12:00 p.m. Tune in for your daily dose of all things crypto. Make sure to also check out Yahoo Finance's new crypto hub to find the latest crypto-related news.
INTC
Will Nvidia Form the $6 Trillion Club on May 20?
The world's most valuable company can move markets with its quarterly earnings report, but there's a bigger prize for long-term investors.